Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC

NCT02194556 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

EGFR Positive Non-small Cell Lung Cancer
Adenocarcinoma

Interventions

DRUG: Sequential and maintenance icotinib
DRUG: Maintenance icotinib

Sponsor

Betta Pharmaceuticals Co., Ltd.